Non-inferiority efficacy trial of risperidone long-acting injection vs. olanzapine tablets

被引：0
|
作者：
Rabinowitz, J [1 ]
Khan, A [1 ]
Augustyns, I [1 ]
Ingham, M [1 ]
机构：
[1] Bar Ilan Univ, IL-52100 Ramat Gan, Israel
来源：
SCHIZOPHRENIA RESEARCH | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [41] Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
    Citrome, Leslie
    PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 345 - 355
  • [42] A mirror-image study of risperidone long-acting injection
    Young, C
    Taylor, D
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A11 - A11
  • [43] Risperidone long-acting injection: Prognostic indicators for early discontinuation
    Patel, MX
    Young, C
    Samele, C
    Taylor, DM
    David, AS
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 175 - 175
  • [44] Explicit review of risperidone long-acting injection prescribing practice
    Wheeler, A.
    Vanderpyl, J.
    Carswell, C.
    Stojkovic, M.
    Robinson, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (06) : 651 - 663
  • [45] Prognostic indicators for early discontinuation of risperidone long-acting injection
    Patel, MX
    Young, C
    Samele, C
    Taylor, DM
    David, AS
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (04) : 233 - 239
  • [46] Patients' acceptance of the deltoid application of risperidone long-acting injection
    Heres, Stephan
    Frobose, Teresa
    Hamann, Johannes
    Leucht, Stefan
    Maino, Katja
    Reichhart, Tatjana
    Stiegler, Michaela
    Kissling, Werner
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 897 - 901
  • [47] The Disparity of Pharmacokinetics and Prolactin Study for Risperidone Long-Acting Injection
    Peng, Po-Wei
    Huang, Ming-Chyi
    Tsai, Chang-Jer
    Pan, Chun-Hung
    Chen, Chiao-Chicy
    Chiu, Chih-Chiang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (06) : 726 - 727
  • [48] Long-acting risperidone injection reduces healthcare resource use
    Hagström, P
    Mehnert, A
    Leal, A
    Gefvert, O
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 98 - 98
  • [49] Economic analysis of risperidone long-acting injection in New Zealand
    Davies, A
    Schrover, R
    Crowley, S
    Neville, AM
    VALUE IN HEALTH, 2004, 7 (06) : 779 - 779
  • [50] Clinical improvement with long-acting risperidone in patients previously receiving oral olanzapine
    Jones, R
    Lasser, R
    Bossie, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S303 - S304
12345